Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Ophthalmol ; 31(4): 1584-1587, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33631984

ABSTRACT

PURPOSE: Ocular features of Alport syndrome include anterior lenticonus, posterior polymorphous corneal dystrophy, and fleck-and-dot retinopathy in most cases. Keratoconus in such patients has been rarely mentioned in previous studies. To our knowledge, this is the first report of corneal cross-linking for halting the progression of keratoconus in a patient with Alport syndrome. CASE REPORT: A 22-year-old male was referred for his initial corneal topography, after he was already prescribed with rigid gas-permeable contact lenses. Alport syndrome was diagnosed in his infancy and gene COL4A5 mutation was confirmed. Ophthalmological evaluation confirmed keratoconus. One-year follow-up showed a progression on his right eye and standard corneal cross-linking was performed. Stabilization of the disease marked by normalization in visual function and corneal tomography values was noticed 1 year after the procedure. CONCLUSIONS: When diagnosing ocular clinical findings of Alport syndrome, keratoconus should be considered. Standard corneal cross-linking protocol can halt its progression.


Subject(s)
Corneal Dystrophies, Hereditary , Keratoconus , Nephritis, Hereditary , Photochemotherapy , Adult , Cornea , Corneal Dystrophies, Hereditary/diagnosis , Corneal Dystrophies, Hereditary/drug therapy , Corneal Topography , Cross-Linking Reagents/therapeutic use , Humans , Keratoconus/diagnosis , Keratoconus/drug therapy , Male , Nephritis, Hereditary/complications , Nephritis, Hereditary/diagnosis , Nephritis, Hereditary/drug therapy , Photosensitizing Agents/therapeutic use , Riboflavin/therapeutic use , Ultraviolet Rays , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...